Sarepta Therapeutics (SRPT) is a publicly traded Healthcare sector company. As of August 27, 2026, SRPT trades at $19.22 with a market cap of $2.00B and a P/E ratio of -14.05. SRPT moved -1.52% today. Year to date, SRPT is -8.68%; over the trailing twelve months it is +6.57%. Its 52-week range spans $10.42 to $129.84. Analyst consensus is neutral with an average price target of $22.87. Rallies surfaces SRPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks SRPT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $19.22 |
| Market Cap | $2.00B |
| P/E Ratio | -14.05 |
| EPS | $-1.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $129.84 |
| 52-Week Low | $10.42 |
| Volume | 298.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.97B |
| Net Income | $-136.72M |
| Gross Margin | 0.00% |
16 analysts cover SRPT: 0 strong buy, 5 buy, 7 hold, 4 sell, 0 strong sell. Consensus rating is neutral. Average price target: $22.87.